MIRM
Mirum Pharmaceuticals, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:58:29 PM EST
95.37USD+3.114%(+2.88)620,400
Pre-marketNov 19, 2026 9:27:30 AM EST
92.40USD-0.097%(-0.09)
MIRM Financials
In Q3 FY 2026 (ended ), Mirum Pharmaceuticals, Inc. Common Stock (MIRM) reported revenue of $185.72M, net income of −$40.77M, operating cash flow of −$4.31M, and assets of $1.03B (filed ).
Loading financial statements…